FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

38112003: 1 (kwalificatiewaarde)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    12718871000146116 1 (kwalificatiewaarde) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
    12718881000146119 één nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
    13856651000146112 1 nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 (kwalificatiewaarde) Is a General adjectival modifier false Inferred relationship Some
    1 (kwalificatiewaarde) Is a Number false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing only inotersen in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only sufentanil in sublingual dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Inotersen only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only baloxavir marboxil in oral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only gilteritinib in oral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only lorlatinib (medicinal product) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Larotrectinib only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Gilteritinib only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Amifampridine only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only revefenacin in oral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Lorlatinib only product in oral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing only larotrectinib in oral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Amifampridine only product in oral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Revefenacin only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely dexamfetamine sulfate 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely dexamfetamine sulfate 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely chlorphenamine maleate 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely chlorphenamine maleate 4 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Emapalumab only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Glasdegib only product Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Almotriptan (as almotriptan malate) 12.5 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Almotriptan (as almotriptan malate) 12.5 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Cefalexin 500 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Cefalexin 500 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Afatinib (as afatinib dimaleate) 40 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Afatinib (as afatinib dimaleate) 40 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Afatinib (as afatinib dimaleate) 20 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Afatinib (as afatinib dimaleate) 20 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Buspirone hydrochloride 10 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Buspirone hydrochloride 10 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Distigmine bromide 5 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Distigmine bromide 5 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely bisoprolol fumarate 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Product containing precisely bisoprolol fumarate 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely trientine hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely trientine hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely amitriptyline hydrochloride 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely amitriptyline hydrochloride 10 milligram and perphenazine 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Buspirone hydrochloride 5 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Buspirone hydrochloride 5 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely bosutinib (as bosutinib monohydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely bosutinib (as bosutinib monohydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing only glasdegib in oral dose form (medicinal product form) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely dihydrocodeine tartrate 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely diphenhydramine hydrochloride 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely diphenhydramine hydrochloride 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely dextropropoxyphene hydrochloride 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Product containing precisely dextropropoxyphene hydrochloride 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely menadiol (as menadiol sodium diphosphate) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely menadiol (as menadiol sodium diphosphate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Dihydrocodeine tartrate 30 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Dihydrocodeine tartrate 30 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Emapalumab only product in parenteral dose form Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely bosutinib (as bosutinib monohydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely bosutinib (as bosutinib monohydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Amitriptyline hydrochloride 25 mg and perphenazine 2 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Amitriptyline hydrochloride 25 mg and perphenazine 2 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Afatinib (as afatinib dimaleate) 30 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Afatinib (as afatinib dimaleate) 30 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Aliskiren (as aliskiren fumarate) 150 mg oral tablet Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Aliskiren (as aliskiren fumarate) 150 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely tofacitinib (as tofacitinib citrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely tofacitinib (as tofacitinib citrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely sibutramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely sibutramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely pethidine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely pethidine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely lisuride maleate 200 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Product containing precisely lisuride maleate 200 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Metoclopramide hydrochloride 5 mg and paracetamol 500 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 2
    Metoclopramide hydrochloride 5 mg and paracetamol 500 mg oral tablet Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely indoramin (as indoramin hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 (kwalificatiewaarde) Inferred relationship Some 1
    Product containing precisely indoramin (as indoramin hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some
    Sibutramine hydrochloride 15 mg oral capsule Count of base of active ingredient False 1 (kwalificatiewaarde) Inferred relationship Some

    Start Previous Page 165 of 215 Next End


    Reference Sets

    Concept inactivation indicator reference set

    Back to Start